Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy (2204)

Diggs, A., Dioun, S., Chen, L., St. Clair, C., de Meritens, A. B., Hou, J., Khoury-Collado, F., & Wright, J. (2023). Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy (2204). Gynecologic Oncology, 176, S259. https://doi.org/10.1016/j.ygyno.2023.06.324
Authors:
Alexandra Diggs
Shayan Dioun
Ling Chen
Caryn St. Clair
Alexandre Buckley de Meritens
June Y. Hou
Fady Khoury‐Collado
Jason D. Wright
Affiliated Authors:
Alexandra Diggs
Shayan Dioun
Columbia Affiliation:
Subjects:
Molecular Characterization of Colorectal Cancer (OpenAlex Topic)
Gynecologic Oncology (OpenAlex Topic)
Diagnosis and Management of Endometriosis (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.ygyno.2023.06.324
DOI:
10.1016/j.ygyno.2023.06.324
Journal:
Gynecologic Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: